Published in J Clin Microbiol on June 01, 2006
Molecular phylogenetics of Candida albicans. Eukaryot Cell (2007) 2.41
Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing. J Clin Microbiol (2006) 1.43
Multilocus sequence typing of pathogenic Candida species. Eukaryot Cell (2008) 1.27
Genetic diversity among Korean Candida albicans bloodstream isolates: assessment by multilocus sequence typing and restriction endonuclease analysis of genomic DNA by use of BssHII. J Clin Microbiol (2011) 1.20
Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing. J Clin Microbiol (2007) 1.18
Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans. J Clin Microbiol (2007) 1.06
Identification, typing, antifungal resistance profile, and biofilm formation of Candida albicans isolates from Lebanese hospital patients. Biomed Res Int (2014) 0.82
Analysis of the clonality of Candida tropicalis strains from a general hospital in Beijing using multilocus sequence typing. PLoS One (2012) 0.81
Molecular fingerprints to identify Candida species. Biomed Res Int (2013) 0.81
Genetic relationships between Candida albicans strains isolated from dental plaque, trachea, and bronchoalveolar lavage fluid from mechanically ventilated intensive care unit patients. J Oral Microbiol (2011) 0.81
Particular Candida albicans strains in the digestive tract of dyspeptic patients, identified by multilocus sequence typing. PLoS One (2012) 0.81
Multilocus sequence typing of Candida tropicalis shows the presence of different clonal clusters and fluconazole susceptibility profiles in sequential isolates from candidemia patients in Sao Paulo, Brazil. J Clin Microbiol (2012) 0.80
Multilocus sequence typing for Candida albicans isolates from candidemic patients: comparison with Southern blot hybridization and pulsed-field gel electrophoresis analysis. Korean J Lab Med (2011) 0.79
Multilocus sequence typing of the porcine and human gastric pathogen Helicobacter suis. J Clin Microbiol (2013) 0.79
Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study. Antimicrob Agents Chemother (2015) 0.78
Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A (1998) 39.20
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis (2004) 20.99
Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis (2003) 7.09
Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol (2004) 4.51
Multilocus sequence typing: molecular typing of bacterial pathogens in an era of rapid DNA sequencing and the internet. Curr Opin Microbiol (1999) 4.17
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis (1999) 3.92
Usefulness of multilocus sequence typing for characterization of clinical isolates of Candida albicans. J Clin Microbiol (2002) 3.01
The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev (2000) 2.95
Concordance of gene genealogies reveals reproductive isolation in the pathogenic fungus Coccidioides immitis. Proc Natl Acad Sci U S A (1997) 2.91
Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencing. J Clin Microbiol (1995) 2.74
The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis (1998) 2.65
Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J Clin Microbiol (2003) 2.18
Optimization and validation of multilocus sequence typing for Candida albicans. J Clin Microbiol (2003) 2.18
Collaborative consensus for optimized multilocus sequence typing of Candida albicans. J Clin Microbiol (2003) 2.17
Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol (1999) 2.15
Population structure and properties of Candida albicans, as determined by multilocus sequence typing. J Clin Microbiol (2005) 2.04
Multilocus sequence typing for differentiation of strains of Candida tropicalis. J Clin Microbiol (2005) 1.66
Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol (1997) 1.38
Multilocus sequence typing is a reliable alternative method to DNA fingerprinting for discriminating among strains of Candida albicans. J Clin Microbiol (2004) 1.33
Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres. J Hosp Infect (2005) 1.32
Species identification of medically important fungi by use of real-time LightCycler PCR. J Med Microbiol (2003) 1.26
Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol (2004) 1.22
Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years. J Antimicrob Chemother (2003) 1.22
The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood. J Antimicrob Chemother (2003) 1.16
Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species. J Clin Microbiol (2005) 1.15
An increase in switching frequency correlates with an increase in recombination of the ribosomal chromosomes of Candida albicans strain 3153A. Microbiology (1994) 1.12
Stability of allelic frequencies and distributions of Candida albicans microsatellite loci from U.S. population-based surveillance isolates. J Clin Microbiol (2003) 1.09
Evidence for a more recently evolved clade within a Candida albicans North American population. Microbiology (2001) 1.03
Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect (2003) 1.03
Population structure of Candida albicans, a member of the human flora, as determined by microsatellite loci. Infect Genet Evol (2002) 0.96
High-frequency occurrence of chromosome translocation in a mutant strain of Candida albicans by a suppressor mutation of ploidy shift. Yeast (2000) 0.94
'Genotypic shuffling' of sequential clones of Candida albicans in HIV-infected individuals with and without symptomatic oral candidiasis. J Med Microbiol (2003) 0.92
Comparison of four molecular typing methods to assess genetic relatedness of Candida albicans clinical isolates in Taiwan. J Med Microbiol (2005) 0.91
Significance of amplified fragment length polymorphism in identification and epidemiological examination of Candida species colonization in children undergoing allogeneic stem cell transplantation. J Clin Microbiol (2004) 0.89
Yeast carriage on hands of hospital personnel working in intensive care units. J Hosp Infect (1998) 0.88
Outbreak of Candida albicans fungaemia in a neonatal intensive care unit. Scand J Infect Dis (1998) 0.86
Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients. Epidemiol Infect (2006) 0.83
Molecular epidemiology of Candida colonizing critically ill patients in intensive care units. J Formos Med Assoc (2001) 0.82
Surveillance of nosocomial transmission of Candida albicans in an intensive care unit by DNA fingerprinting. J Hosp Infect (2003) 0.81
Molecular heterogeneity of fluconazole-resistant and -susceptible oral Candida albicans isolates within a single geographic locale. APMIS (2002) 0.79
Oropharyngeal candidosis in AIDS patients: an epidemiological study using restriction analysis of Candida albicans total genomic DNA. Mycoses (1999) 0.77
Epidemiological typing of Candida albicans from bloodstream infections by restriction enzyme analysis. Scand J Infect Dis (2001) 0.77
Subtyping and antifungal susceptibilities of Candida spp. in the intensive care unit of a Greek general hospital. Int J Antimicrob Agents (2001) 0.77
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis (2002) 4.56
Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest (2006) 4.45
Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol (2005) 3.93
Fungal morphogenesis and host invasion. Curr Opin Microbiol (2002) 3.01
Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway. Mol Microbiol (2002) 3.01
Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol (2005) 3.00
Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study. Crit Care Med (2015) 2.91
Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryot Cell (2004) 2.63
Molecular phylogenetics of Candida albicans. Eukaryot Cell (2007) 2.41
Immune recognition of Candida albicans beta-glucan by dectin-1. J Infect Dis (2007) 2.24
Optimization and validation of multilocus sequence typing for Candida albicans. J Clin Microbiol (2003) 2.18
Niche-specific regulation of central metabolic pathways in a fungal pathogen. Cell Microbiol (2006) 2.12
Population structure and properties of Candida albicans, as determined by multilocus sequence typing. J Clin Microbiol (2005) 2.04
Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses (2005) 1.98
Outer chain N-glycans are required for cell wall integrity and virulence of Candida albicans. J Biol Chem (2005) 1.95
An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov (2010) 1.78
Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. J Biol Chem (2005) 1.77
Candida albicans Pmr1p, a secretory pathway P-type Ca2+/Mn2+-ATPase, is required for glycosylation and virulence. J Biol Chem (2005) 1.70
Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis (2008) 1.67
The Candida albicans CaACE2 gene affects morphogenesis, adherence and virulence. Mol Microbiol (2004) 1.66
Mnt1p and Mnt2p of Candida albicans are partially redundant alpha-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence. J Biol Chem (2004) 1.66
Multilocus sequence typing for differentiation of strains of Candida tropicalis. J Clin Microbiol (2005) 1.66
Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. Clin Infect Dis (2010) 1.60
Recognition and blocking of innate immunity cells by Candida albicans chitin. Infect Immun (2011) 1.54
Glucose promotes stress resistance in the fungal pathogen Candida albicans. Mol Biol Cell (2009) 1.52
Loss of cell wall mannosylphosphate in Candida albicans does not influence macrophage recognition. J Biol Chem (2004) 1.51
Infection-related gene expression in Candida albicans. Curr Opin Microbiol (2007) 1.50
GFP as a quantitative reporter of gene regulation in Candida albicans. Yeast (2004) 1.47
Neuromuscular disorders in severe acute respiratory syndrome. Arch Neurol (2004) 1.46
Developmental regulation of an adhesin gene during cellular morphogenesis in the fungal pathogen Candida albicans. Eukaryot Cell (2007) 1.45
Niche-specific activation of the oxidative stress response by the pathogenic fungus Candida albicans. Infect Immun (2007) 1.42
Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection. Antimicrob Agents Chemother (2010) 1.39
Genome-wide analysis of Candida albicans gene expression patterns during infection of the mammalian kidney. Fungal Genet Biol (2008) 1.37
Property differences among the four major Candida albicans strain clades. Eukaryot Cell (2009) 1.36
Genetic evidence for recombination in Candida albicans based on haplotype analysis. Fungal Genet Biol (2004) 1.33
Animal models of mucosal Candida infection. FEMS Microbiol Lett (2008) 1.33
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections. Int J Antimicrob Agents (2009) 1.32
Strain typing and determination of population structure of Candida krusei by multilocus sequence typing. J Clin Microbiol (2006) 1.31
Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections. PLoS One (2009) 1.31
Endoplasmic reticulum alpha-glycosidases of Candida albicans are required for N glycosylation, cell wall integrity, and normal host-fungus interaction. Eukaryot Cell (2007) 1.29
Species identification of medically important fungi by use of real-time LightCycler PCR. J Med Microbiol (2003) 1.26
Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method. BMC Infect Dis (2010) 1.26
Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo. Antimicrob Agents Chemother (2011) 1.25
Longitudinal analysis of chlorhexidine susceptibilities of nosocomial methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan. J Antimicrob Chemother (2008) 1.24
CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1. Antimicrob Agents Chemother (2004) 1.24
Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol (2004) 1.22
Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect (2011) 1.22
Genome sequence of a dominant, multidrug-resistant Acinetobacter baumannii strain, TCDC-AB0715. J Bacteriol (2011) 1.22
Compliance of health care workers with hand hygiene practices: independent advantages of overt and covert observers. PLoS One (2013) 1.22
Clinical presentations, laboratory results and outcomes of patients with Kikuchi's disease: emphasis on the association between recurrent Kikuchi's disease and autoimmune diseases. J Microbiol Immunol Infect (2010) 1.19
Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis (2004) 1.18
Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing. J Clin Microbiol (2007) 1.18
Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis (2007) 1.17
Virological, serological, and antiviral studies in an imported human case of avian influenza A(H7N9) virus in Taiwan. Clin Infect Dis (2013) 1.16
Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species. J Clin Microbiol (2005) 1.15
Methicillin-resistant Staphylococcus aureus in Taiwan. Emerg Infect Dis (2005) 1.14
Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan. Int J Antimicrob Agents (2010) 1.13
Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes. J Antimicrob Chemother (2005) 1.13
Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis (2004) 1.13
Molecular epidemiological identification of Neisseria gonorrhoeae clonal clusters with distinct susceptibility profiles associated with specific groups at high risk of contracting human immunodeficiency virus and syphilis. J Clin Microbiol (2008) 1.13
Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis (2004) 1.12
Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole. Diagn Microbiol Infect Dis (2007) 1.12
Glycosylation status of the C. albicans cell wall affects the efficiency of neutrophil phagocytosis and killing but not cytokine signaling. Med Mycol (2011) 1.12
Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection. J Microbiol Immunol Infect (2011) 1.11
Genotyping of Chlamydia trachomatis from clinical specimens in Taiwan. J Med Microbiol (2006) 1.11
Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa. FEMS Microbiol Lett (2008) 1.11
Comparison of an automated repetitive-sequence-based PCR microbial typing system with pulsed-field gel electrophoresis for molecular typing of vancomycin-resistant Enterococcus faecium. J Clin Microbiol (2010) 1.09
Global role of the protein kinase Gcn2 in the human pathogen Candida albicans. Eukaryot Cell (2005) 1.09
Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species. BMC Infect Dis (2005) 1.09
Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. Antimicrob Agents Chemother (2005) 1.08
The evolutionary rewiring of ubiquitination targets has reprogrammed the regulation of carbon assimilation in the pathogenic yeast Candida albicans. MBio (2012) 1.08
Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus. J Clin Microbiol (2007) 1.07
Candida albicans Iff11, a secreted protein required for cell wall structure and virulence. Infect Immun (2007) 1.07
Distribution of Staphylococcal cassette chromosome mec Types and correlation with comorbidity and infection type in patients with MRSA bacteremia. PLoS One (2010) 1.06
Antioxidant and pancreas-protective effect of aucubin on rats with streptozotocin-induced diabetes. Eur J Pharmacol (2007) 1.06
Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection. Antimicrob Agents Chemother (2004) 1.06
Molecular epidemiology and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in Taiwan. Diagn Microbiol Infect Dis (2002) 1.05
Molecular mechanisms of fluoroquinolone resistance. J Microbiol Immunol Infect (2003) 1.05
Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis. BMC Infect Dis (2014) 1.04
Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. J Virol (2006) 1.04
Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus. J Med Virol (2004) 1.04
A multifunctional mannosyltransferase family in Candida albicans determines cell wall mannan structure and host-fungus interactions. J Biol Chem (2010) 1.04
Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology. J Med Chem (2005) 1.04
Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010. PLoS One (2013) 1.04
Draft genome sequence of a dominant, multidrug-resistant Neisseria gonorrhoeae strain, TCDC-NG08107, from a sexual group at high risk of acquiring human immunodeficiency virus infection and syphilis. J Bacteriol (2011) 1.03
Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol (2007) 1.03
Infections occurring during extracorporeal membrane oxygenation use in adult patients. J Thorac Cardiovasc Surg (2010) 1.03
Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Int J STD AIDS (2003) 1.03
Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect (2003) 1.03
Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Diagn Microbiol Infect Dis (2005) 1.01